Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Hypera SA (OTC: HYPMY).

Full DD Report for HYPMY

You must become a subscriber to view this report.


Recent News from (OTC: HYPMY)

50 Healthcare Top Yield Equities For April
Actionable Conclusions (1-10): Analysts Predicted 9.8% To 41.2% Net Gains For Top Ten Healthcare Equities By April 2019 Two of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. ...
Source: SeekingAlpha
Date: April, 10 2018 09:58
Healthcare Top Gainers: Sanofi, Merck, Glaxo, Patterson, And AstraZeneca By Broker February Targets
Actionable Conclusions (1-10): Analysts Predicted 4.22% To 26.43% Net Gains For Top Ten Healthcare Equities By February 2019 Four of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. (...
Source: SeekingAlpha
Date: March, 01 2018 14:28
Hypera SA ADR 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Hypera SA ADR in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: February, 27 2018 13:49
Healthcare Net Gain Leaders: Getinge, Glaxo, Sanofi, Merck And Medical Facilities By Broker January Target Reckoning
Actionable Conclusions (1-10): Analysts Predicted 3.18% To 23.18% Net Gains For Top Ten Healthcare Dogs By January 2019 Seven of ten top dividend-yielding Healthcare dogs were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. ...
Source: SeekingAlpha
Date: January, 28 2018 01:20
The 25 most potent corporate reputations in Brazil contribute US$180 billion of shareholder value
SAO PAULO , Nov. 29, 2017 /PRNewswire/ -- Reputation Dividend ( www.reputationdividend.com ), in association with MZ" ( www.mzgroup.com ), announced today the 2017 Brazil Reputation Dividend Report. This third annual report confirms that corporate reputations of Brazil's leading co...
Source: PR Newswire
Date: November, 29 2017 12:53
Hypermarcas SA ADR 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by Hypermarcas SA ADR in conjunction with their 2017 Q3 earnings Read more ...
Source: SeekingAlpha
Date: October, 31 2017 14:11
In Healthcare Sector GlaxoSmithKline Remains Top Broker Pick For Gains In September
Actionable Conclusions (1-10): Analysts Predicted 3% To 18.8% Net Gains For Ten Healthcare Dogs By September 2018 Five of ten top dividend-yielding Healthcare dogs were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices...
Source: SeekingAlpha
Date: September, 11 2017 04:30
GlaxoSmithKline Is Broker Pick As Top Dog For Healthcare Sector Gains In August
Actionable Conclusions (1-10): Analysts Predicted 9.4% To 20.8% Net Gains For Ten Healthcare Dogs By August 2018 Three of ten top dividend-yielding Healthcare dogs were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. (They are ti...
Source: SeekingAlpha
Date: August, 09 2017 20:22
Healthcare Has GlaxoSmithKline As Top Dog By Gains In June
Actionable Conclusions (1-10): Analysts Predicted 3% To 11.5% Net Gains For 10 Healthcare Dogs By June 2018 Six of ten top dividend-yielding Healthcare dogs were verified as being among the top 10 of 30 gainers for the coming year based on analyst one-year target prices (As tinted gray...
Source: SeekingAlpha
Date: July, 01 2017 05:06
Books will close today June 29th, 2017.
Books will close today June 29th, 2017.
Source: OTC Markets
Date: June, 29 2017 00:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-147.257.3957.3957.2216,016
2018-08-136.947.2657.316.9413,701
2018-08-107.006.9837.0476.968,583
2018-08-097.327.367.407.27314,543
2018-08-087.767.447.767.447,725

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-153,58511,76130.4821Cover
2018-08-141,31516,0168.2105Cover
2018-08-137,99213,70158.3315Short
2018-08-102,1728,58325.3058Cover
2018-08-091,50513,49311.1539Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on HYPMY.


About Hypera SA (OTC: HYPMY)

Logo for Hypera SA (OTC: HYPMY)

Hypermarcas SA manufactures and markets in Brasil a wide range of health and consumer goods products through its own proprietary brands in two sectors: lt br / gt lt br / gt Pharmaceuticals and lt br / gt lt br / gt Personal care. lt br / gt lt br / gt The company s pharmaceutical products are over the counter, generics and prescription medication. Hypermarcas also offers personal care products, such as health and beauty, diapers and other disposables.

 

Contact Information

 

 

Current Management

  • Nelson Jose de Mello / Institutional Relations Officer
  • Claudio Bergamo dos Santos / CEO
  • Nicolas Fischer / President, Consumer Division
  • Luiz Eduardo Violland / President, Pharmaceutical Division
  • Carlos Roberto Scorsi / COO
  • Martim Prado Mattos / CFO
  • Gabriela Bueno Garcia / Strategic Planning Executive Officer
  • Breno Toledo Pires de Oliveira / Chief Investor Relations Officer, Treasurer
  • Antonio Carlos Vanzelotti / Controllership Executive Officer
  • Renato Braun / IR
  • Leandro Gomes / IR Manager
  • Armando Luis Ferreira / Tax Officer
  • Joao Alves de Queiroz Filho / Chairman
  • Marcelo Goncalves Filho /
  • Luciana Cavalheiro Fleischner /
  • Esteban Malpica Fomperosa /
  • Marcelo Goncalves /
  • Bernardo Malpica Hernandez /
  • Jairo Eduardo Loureiro /
  • David Coury Neto /

Current Share Structure

  • Market Cap: $7,184,457,545 - 03/09/2018
  • Issue and Outstanding: 632,100,787 - 11/04/2013
  • Float: 366,728,576 - 06/30/2012

 


Recent Filings from (OTC: HYPMY)

Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: February, 15 2018
Filing to become effective immediately upon filing
Filing Type: F-6EFFiling Source: edgar
Filing Date: December, 09 2015

 

 


Daily Technical Chart for (OTC: HYPMY)

Daily Technical Chart for (OTC: HYPMY)


Stay tuned for daily updates and more on (OTC: HYPMY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: HYPMY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in HYPMY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of HYPMY and does not buy, sell, or trade any shares of HYPMY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/